1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Growth Hormone Deficiency-Pipeline Insights, 2016

Growth Hormone Deficiency-Pipeline Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 60 pages


DelveInsight’s, “ Growth Hormone Deficiency-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Deficiency. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Growth Hormone Deficiency. DelveInsight’s Report also assesses the Growth Hormone Deficiency therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Growth Hormone Deficiency
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Growth Hormone Deficiency pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Growth Hormone Deficiency and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Growth Hormone Deficiency-Pipeline Insights, 2016

Illustrative Table of contents

- Growth Hormone Deficiency Overview
- Growth Hormone Deficiency Pipeline Therapeutics
- Growth Hormone Deficiency Therapeutics under Development by Companies
- Growth Hormone Deficiency Filed and Phase III Products
- Comparative Analysis
- Growth Hormone Deficiency Phase II Products
- Comparative Analysis
- Growth Hormone Deficiency Phase I and IND Filed Products
- Comparative Analysis
- Growth Hormone Deficiency Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Growth Hormone Deficiency - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Growth Hormone Deficiency - Discontinued Products
- Growth Hormone Deficiency - Dormant Products
- Companies Involved in Therapeutics Development for Growth Hormone Deficiency
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Growth Hormone Deficiency, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Growth Hormone Deficiency Assessment by Monotherapy Products
- Growth Hormone Deficiency Assessment by Combination Products
- Growth Hormone Deficiency Assessment by Route of Administration
- Growth Hormone Deficiency Assessment by Stage and Route of Administration
- Growth Hormone Deficiency Assessment by Molecule Type
- Growth Hormone Deficiency Assessment by Stage and Molecule Type
- Growth Hormone Deficiency Therapeutics - Discontinued Products
- Growth Hormone Deficiency Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Growth Hormone Deficiency, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Growth Hormone Deficiency Assessment by Monotherapy Products
- Growth Hormone Deficiency Assessment by Combination Products
- Growth Hormone Deficiency Assessment by Route of Administration
- Growth Hormone Deficiency Assessment by Stage and Route of Administration
- Growth Hormone Deficiency Assessment by Molecule Type
- Growth Hormone Deficiency Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast-2023

Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Growth Hormone Deficiency (GHD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Growth Hormone Deficiency ...

Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023

Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Growth Hormone Deficiency (GHD)  in seven major markets (US, France, ...

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.